Lawsuit Alert: Investors in shares of Humana Inc. (NYSE: HUM) should contact the Shareholders Foundation

Core Viewpoint - The ongoing lawsuit against Humana Inc. involves allegations of securities law violations related to misleading statements about the company's financial health and the impact of pent-up demand for healthcare services post-COVID [2]. Group 1: Lawsuit Details - An investor filed a lawsuit on June 4, 2024, claiming that Humana misled investors regarding in-patient unit costs and the absence of pent-up demand for healthcare services, which ultimately affected utilization rates and profitability [2]. - The lawsuit alleges that despite assurances from the company, increased medical costs associated with pent-up demand were not adequately disclosed, leading to higher utilization rates and costs contrary to the company's statements [2]. - An amended complaint was filed on November 20, 2024, and the defendants submitted motions to dismiss the case on April 24, 2025 [3]. Group 2: Investor Information - Investors who purchased shares of Humana Inc. prior to July 2022 and continue to hold those shares are encouraged to contact the Shareholders Foundation for potential options related to the lawsuit [1][3]. - The Shareholders Foundation provides services related to shareholder issues, including information on securities class actions and legal news relevant to the financial market [3].